Skip to main content
. 2017 May 12;8(8):1338–1346. doi: 10.7150/jca.18030

Figure 3.

Figure 3

Recurrence prediction values using serum IgG4 levels in patients with low-recurrence risk. Kaplan-Meier analysis of HCC patients with AFP <400 ng/ml (A), BCLC 0+A (B), single tumor (C), and no satellite lesion (D) in the training and validation cohorts.